MX2019004393A - Pharmaceutical composition comprising drospirenone and contraceptive kit. - Google Patents
Pharmaceutical composition comprising drospirenone and contraceptive kit.Info
- Publication number
- MX2019004393A MX2019004393A MX2019004393A MX2019004393A MX2019004393A MX 2019004393 A MX2019004393 A MX 2019004393A MX 2019004393 A MX2019004393 A MX 2019004393A MX 2019004393 A MX2019004393 A MX 2019004393A MX 2019004393 A MX2019004393 A MX 2019004393A
- Authority
- MX
- Mexico
- Prior art keywords
- drospirenone
- pharmaceutical composition
- contraceptive kit
- present
- contraceptive
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The present invention relates to the field of pharmaceutical compositions and contraceptive methods. The present invention provides a pharmaceutical composition comprising drospirenone characterized by a slow dissolution rate of drospirenone in vitro and an improved pharmacokinetic profile. The use of the said composition in contraceptive methods and kits are also provided.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10305708 | 2010-06-29 | ||
| US36839610P | 2010-07-28 | 2010-07-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2019004393A true MX2019004393A (en) | 2019-09-09 |
Family
ID=48802149
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015008884A MX364971B (en) | 2010-06-29 | 2011-06-28 | Pharmaceutical composition comprising drospirenone and contraceptive kit. |
| MX2012014629A MX339952B (en) | 2010-06-29 | 2011-06-28 | Pharmaceutical composition comprising drospirenone and contraceptive kit. |
| MX2019004393A MX2019004393A (en) | 2010-06-29 | 2012-12-13 | Pharmaceutical composition comprising drospirenone and contraceptive kit. |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015008884A MX364971B (en) | 2010-06-29 | 2011-06-28 | Pharmaceutical composition comprising drospirenone and contraceptive kit. |
| MX2012014629A MX339952B (en) | 2010-06-29 | 2011-06-28 | Pharmaceutical composition comprising drospirenone and contraceptive kit. |
Country Status (14)
| Country | Link |
|---|---|
| KR (1) | KR102210982B1 (en) |
| BR (1) | BR122019008317A2 (en) |
| CL (1) | CL2012003685A1 (en) |
| CO (1) | CO6640328A2 (en) |
| DK (1) | DK2588114T3 (en) |
| EC (3) | ECSP12012359A (en) |
| ES (1) | ES2777886T3 (en) |
| GT (3) | GT201200336BA (en) |
| HR (1) | HRP20200155T1 (en) |
| HU (1) | HUE047689T2 (en) |
| LT (2) | LT2588114T (en) |
| MX (3) | MX364971B (en) |
| PT (1) | PT2588114T (en) |
| ZA (1) | ZA201209743B (en) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009138224A1 (en) * | 2008-05-14 | 2009-11-19 | Helm Ag | Pharmaceutical composition comprising drospirenone |
-
2011
- 2011-06-28 MX MX2015008884A patent/MX364971B/en unknown
- 2011-06-28 DK DK11727985.1T patent/DK2588114T3/en active
- 2011-06-28 BR BR122019008317-7A patent/BR122019008317A2/en not_active Application Discontinuation
- 2011-06-28 HU HUE11727985A patent/HUE047689T2/en unknown
- 2011-06-28 KR KR1020197017379A patent/KR102210982B1/en active IP Right Grant
- 2011-06-28 PT PT117279851T patent/PT2588114T/en unknown
- 2011-06-28 ES ES11727985T patent/ES2777886T3/en active Active
- 2011-06-28 LT LTEP11727985.1T patent/LT2588114T/en unknown
- 2011-06-28 MX MX2012014629A patent/MX339952B/en active IP Right Grant
-
2012
- 2012-10-27 EC ECSP12012359 patent/ECSP12012359A/en unknown
- 2012-12-12 GT GT201200336BL patent/GT201200336BA/en unknown
- 2012-12-12 GT GT201200336A patent/GT201200336A/en unknown
- 2012-12-12 GT GT201200336AK patent/GT201200336AA/en unknown
- 2012-12-13 MX MX2019004393A patent/MX2019004393A/en unknown
- 2012-12-21 ZA ZA2012/09743A patent/ZA201209743B/en unknown
- 2012-12-26 CL CL2012003685A patent/CL2012003685A1/en unknown
- 2012-12-28 CO CO12235600A patent/CO6640328A2/en not_active Application Discontinuation
-
2015
- 2015-07-28 EC ECIEPI201532906A patent/ECSP15032906A/en unknown
- 2015-07-28 EC ECIEPI201532911A patent/ECSP15032911A/en unknown
-
2020
- 2020-01-30 HR HRP20200155TT patent/HRP20200155T1/en unknown
-
2021
- 2021-10-14 LT LTPA2021523C patent/LTPA2021523I1/lt unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX364971B (en) | 2019-05-16 |
| BR122019008317A2 (en) | 2020-09-29 |
| GT201200336A (en) | 2014-01-14 |
| ZA201209743B (en) | 2014-03-26 |
| HRP20200155T1 (en) | 2020-05-01 |
| DK2588114T3 (en) | 2020-02-17 |
| KR20190073598A (en) | 2019-06-26 |
| CL2012003685A1 (en) | 2013-07-05 |
| ECSP15032906A (en) | 2016-01-29 |
| CO6640328A2 (en) | 2013-03-22 |
| GT201200336AA (en) | 2017-10-23 |
| ES2777886T3 (en) | 2020-08-06 |
| PT2588114T (en) | 2020-02-20 |
| HUE047689T2 (en) | 2020-05-28 |
| LT2588114T (en) | 2020-02-25 |
| MX339952B (en) | 2016-06-20 |
| ECSP15032911A (en) | 2016-01-29 |
| MX2012014629A (en) | 2013-05-06 |
| KR102210982B1 (en) | 2021-02-02 |
| LTPA2021523I1 (en) | 2021-11-10 |
| GT201200336BA (en) | 2017-10-23 |
| ECSP12012359A (en) | 2013-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUS2000016I1 (en) | Pharmaceutical composition comprising drospirenone and contraceptive kit | |
| MX2012000396A (en) | Methods and compositions for use in cellular therapies. | |
| HK1210717A1 (en) | Stable pharmaceutical composition and methods of using same | |
| MX2015002056A (en) | Geopolymer cement compositions and methods of use. | |
| IL222738A0 (en) | Pharmaceutical emulsion composition comprising progestogen | |
| TN2011000656A1 (en) | Pharmaceutical composition for emergency contraception | |
| TN2012000161A1 (en) | Spiro-oxindole mdm2 antagonists | |
| IL214822A0 (en) | Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof | |
| ZA201100605B (en) | Micronised progesterone pharmaceutical composition and uses thereof | |
| MX348823B (en) | Stable formulations of linaclotide. | |
| MX2013002784A (en) | Fused heteroaryls and their uses. | |
| IL232534A0 (en) | Pharmaceutical compositions and methods of use of 4-pregenen-11β-17-21-triol-3,20-dione derivatives | |
| EP2635260A4 (en) | Compositions and methods for the delivery of therapeutics | |
| HK1142608A1 (en) | 5-pyridinone substituted indazoles and pharmaceutical compositions thereof 5- | |
| MX2012010127A (en) | Derivatives of aminoindanes, their preparation and their application in therapeutics. | |
| PH12014500714A1 (en) | Stable sns-595 compositions and methods of preparation | |
| EP2568810A4 (en) | Darunavir compositions | |
| IN2015DN04074A (en) | ||
| MX2019004393A (en) | Pharmaceutical composition comprising drospirenone and contraceptive kit. | |
| GB201405031D0 (en) | Storage stable premixed hydraulic cement compositions, cements, methods, and articles | |
| ZA201105443B (en) | Novel saponin compounds,methods of preparation thereof,use thereof and pharmaceutical compositions | |
| UA59396U (en) | Use of compositions of non-steroid anti-inflammatory drugs and caffeine as antiexudative agents |